LIFESPLICE PHARMA, LLC

Basic Information

1 Great Valley Parkway
Malvern, PA, 19355-1423

Company Profile

n/a

Additional Details

Field Value
DUNS: 965376994
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: Y
Number of Employees: n/a


  1. Preclinical testing of the splice modulating oligonucleotide LSP-GR1

    Amount: $2,758,329.00

    DESCRIPTION (provided by applicant): AMPA glutamate receptors mediate the majority of fast excitatory neurotransmission in the central nervous system. Four AMPA receptor subunits exist, GluA1-GluA4, w ...

    SBIR Phase II 2014 Department of Health and Human Services
  2. Characterizing an AMPA Receptor Splice Modulator in Preventing Epileptogenesis

    Amount: $494,735.00

    DESCRIPTION (provided by applicant): AMPA glutamate receptors mediate the majority of fast excitatory neurotransmission in the brain. Four AMPA receptor subunits exist, GluR1-GluR4, with functiona ...

    SBIR Phase I 2011 Department of Health and Human Services
  3. Oligonucleotides that Modulate AMPA Receptor Alternative Splicing as Drug Candida

    Amount: $458,274.00

    DESCRIPTION (provided by applicant): Amyotrophic lateral sclerosis (ALS) is characterized by the progressive and selective loss of motor neurons (MNs) in the motor cortex, brainstem, and spinal co ...

    SBIR Phase I 2011 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government